Nomura Holdings, Inc. (TYO:8604)

Japan flag Japan · Delayed Price · Currency is JPY
895.00
-2.60 (-0.29%)
Jun 10, 2025, 3:30 PM JST
-7.87%
Market Cap 2.69T
Revenue (ttm) 1.89T
Net Income (ttm) 340.74B
Shares Out 3.00B
EPS (ttm) 111.03
PE Ratio 8.06
Forward PE 8.61
Dividend 48.00 (5.35%)
Ex-Dividend Date Mar 28, 2025
Volume 10,911,300
Average Volume 12,008,730
Open 899.10
Previous Close 897.60
Day's Range 895.00 - 909.80
52-Week Range 656.80 - 1,080.00
Beta 0.57
RSI 61.17
Earnings Date Aug 1, 2025

About Nomura Holdings

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. It operates through three segments: Wealth Management, Investment Management, and Wholesale. The Wealth Management segment offers various financial products and investment consultation services. The Investment Management segment offers investment trust management, discretionary investment services, and investment funds. The Wholesale segment is involved in the sale, trading, services i... [Read more]

Industry Financial - Capital Markets
Sector Financials
Founded 1925
Employees 26,850
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 8604
Full Company Profile

Financial Performance

In 2024, Nomura Holdings's revenue was 1.89 trillion, an increase of 21.16% compared to the previous year's 1.56 trillion. Earnings were 340.74 billion, an increase of 105.43%.

Financial Statements

News

Forexlive European FX news wrap: Awaiting the US-China trade talks outcome

US May NFIB small business optimism index 98.8 vs 95.9 expected Lutnick: Talks with China are going well ECB's Rehn: We will take decisions meeting by meeting Eurozone June Sentix investor confidence ...

13 hours ago - Forexlive

Nomura sees steady outlook for India consumer space, expects rural recovery to strengthen

Nomura has released its latest view on India’s consumer sector, suggesting a gradual recovery in rural demand and a stable urban outlook, albeit with some softness at the bottom-end of the consumption...

21 hours ago - Business Upturn

Nomura: Still Bullish With Latest M&A And New Business Unit

I maintain my buy rating on Nomura Holdings, driven by strategic moves to reduce earnings volatility and enhance returns. The new Trust Banking division will boost recurring revenue, and unlock cross-...

1 day ago - Seeking Alpha

India’s GDP growth likely to slow to 6.2% in FY26: Nomura report

Nomura projects India's GDP growth to slow to 6.2% in FY26, down from 6.5% in FY25, while raising its Nifty target due to positive domestic macroeconomic factors. Bofa Securities expresses caution on ...

8 days ago - The Times of India

Apollo Hospitals stock in focus as Nomura, Morgan Stanley, Citi offer mixed post-Q4 views

Apollo Hospitals will be in focus after global brokerages issued mixed views on the stock following the company’s Q4FY25 earnings. Nomura maintained a Neutral rating with a target price of ₹6,856 per ...

8 days ago - Business Upturn

IPCA Labs in focus as HSBC cuts target, Nomura stays buy post Q4 earnings

IPCA Labs shares will be in focus after HSBC and Nomura released fresh commentary post the company’s Q4FY25 results. HSBC downgraded its target price to ₹1,330 per share and maintained a Hold rating o...

8 days ago - Business Upturn

Nomura hails progress in weaning staff off smoking

Japan’s biggest bank says it has cut proportion of smokers to just under 15%

11 days ago - Financial Times

Japan's Nomura stays committed to growth in U.S. despite turmoil

Nomura (NMR) reaffirmed commitment to expanding its business operations in the U.S., despite recent market turbulence due to global tariff disputes and volatility

11 days ago - Seeking Alpha

Japan's Nomura committed to growth of US business, CEO says

Nomura Holdings , Japan's largest investment bank and brokerage, is committed to growing its business in the United States despite recent market volatility, its chief executive said on Friday.

11 days ago - Reuters

Nomura maintains ‘Neutral’ on Sun Pharma, flags margin risks as investments rise in FY26

Nomura has retained its ‘Neutral’ stance on Sun Pharma with a target price of ₹1,970, stating that Q4FY25 performance came in below expectations, primarily due to lower US revenue contribution. The br...

18 days ago - Business Upturn

Brokerage radar: Hindalco, BEL, Dixon, Zydus, Gland Pharma in focus after Q4; target prices revised

Top brokerages including CLSA, Morgan Stanley, Nomura and Nuvama have released fresh commentary on several Indian stocks following their Q4FY25 results. The reports highlight key upgrades, revised tar...

20 days ago - Business Upturn

Nomura upgrades China stocks to ‘tactical overweight’ after tentative trade breakthrough

Nomura joins other global firms in expressing optimism about Chinese equities following tentative trade deal.

4 weeks ago - South China Morning Post

Citi, Nomura cautious on pharma after US price control move; Sun Pharma seen at risk

Global brokerages Citi and Nomura have flagged potential risks for Indian pharmaceutical companies following the proposed US executive order aimed at slashing drug prices by 30–80%. Both brokerages se...

4 weeks ago - Business Upturn

China needs 'real water stimulus' to revive stocks and stabilize growth, says Nomura

Nomura's Rob Subbaraman warns of looming pressure on ASEAN industries as China redirects exports amid fracturing trade relations with the U.S.

4 weeks ago - CNBC International TV

Nomura pinches JPMorgan managing director

Nomura has hired Cameron Nicholls, JPMorgan’s head of financial sponsors for Australia and New Zealand.

5 weeks ago - The Australian Financial Review

Amid tariff uncertainty markets are ‘in the eye of the storm': Nomura

Chris Willcox, Nomura's head of wholesale and chairman of its investment management division, discusses global markets.

5 weeks ago - CNBC International TV

Amid tariff uncertainty markets are in the eye of the storm: Nomura

Chris Willcox, Nomura's head of wholesale and chairman of its investment management division, discusses global markets.

5 weeks ago - CNBC

Oberoi Realty share price: Nomura sees 23% upside as new project pipeline offsets Thane slowdown

Oberoi Realty Ltd. remains on Nomura’s Buy list despite the brokerage trimming its target price to ₹2,000 per share, citing slower-than-expected sales velocity in the Thane region. At a current market...

5 weeks ago - Business Upturn

Brokerage radar: Bajaj Finance, Trent, BPCL, Ambuja Cement, Oberoi Realty in focus after earnings and estimates

Several large-cap and mid-cap stocks are on the radar of top brokerages following the release of Q4FY25 results and key operational updates. Brokerages including Morgan Stanley, Jefferies, Citi, HSBC ...

5 weeks ago - Business Upturn

Nomura Holdings reports FY results

6 weeks ago - Seeking Alpha

Nomura profits rise 27% amid wild trading under Trump

Revenues from equity services ‘up steeply’ in US due to market volatility

6 weeks ago - Financial Times

The man behind Elliott’s BP battle

Plus, the duo taking on the Big Four and Nomura’s risk-on trading overhaul

6 weeks ago - Financial Times

Stocks to buy today: Here is what top brokerage houses recommended for April 25

Leading brokerage firms have maintained bullish ratings on select Indian companies after the release of Q4 FY25 results. Here’s a breakdown of the top stocks recommended by Jefferies, Nomura, and Morg...

6 weeks ago - Business Upturn

Nomura Eyes Global Growth With $1.8 Billion Macquarie Asset Buyout, Targets Growing AUM To $770 Billion

On Tuesday, Nomura Holdings Inc (NYSE: NMR) disclosed a definitive agreement to acquire Macquarie Group, Ltd .’s (OTC: MCQEF) public asset management operations in the U.S. and Europe in an all-cash...

6 weeks ago - Benzinga